Cipla Limited Stock price

Equities

CIPLA

INE059A01026

Pharmaceuticals

Delayed NSE India Stock Exchange 03:47:43 2023-10-03 am EDT Intraday chart for Cipla Limited 5-day change 1st Jan Change
1184.70 INR -0.12% +1.74% +10.04%
Sales 2024 * 254 B 3,057 M Sales 2025 * 280 B 3,370 M Capitalization 958 B 11 509 M
Net income 2024 * 36,749 M 442 M Net income 2025 * 42,558 M 512 M EV / Sales 2024 *
3,57x
Net cash position 2024 * 48,545 M 583 M Net cash position 2025 * 73,819 M 887 M EV / Sales 2025 *
3,15x
P/E ratio 2024 *
26,1x
P/E ratio 2025 *
22,6x
Employees -
Yield 2024 *
0,60%
Yield 2025 *
0,67%
Free-Float64.30%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.26%
1 week+1.67%
Current month-0.26%
1 month-4.50%
3 months+18.09%
6 months+32.71%
Current year+9.95%
More quotes
1 week
1 158.90
Extreme 1158.9
1 199.20
1 month
1 158.90
Extreme 1158.9
1 267.00
Current year
852.00
Extreme 852
1 277.90
1 year
852.00
Extreme 852
1 277.90
3 years
706.50
Extreme 706.5
1 277.90
5 years
355.30
Extreme 355.3
1 277.90
10 years
355.30
Extreme 355.3
1 277.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 2016
Director/Board Member 82 2011
Corporate Officer/Principal - 2022
Members of the board TitleAgeSince
Chairman 87 1972
Director/Board Member 82 2011
Director/Board Member 48 2015
More insiders
Date Price Change Volume
23-10-03 1184.70 -0.12% 1 057 046
23-09-29 1186.15 +1.90% 1,878,381
23-09-28 1164.05 -1.39% 1,303,811
23-09-27 1180.50 +1.45% 2,165,043
23-09-26 1163.65 -1.33% 1,056,359

Delayed Quote NSE India Stock Exchange, October 03, 2023 at 02:21 am EDT

More quotes
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1186.15INR
Average target price
1178.72INR
Spread / Average Target
-0.63%
Consensus
  1. Markets
  2. Equities
  3. Stock Cipla Limited - NSE India Stock Exchange
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer